Cardiovascular
Psychiatric comorbidities in women with cardiometabolic conditions with and without ADHD: a population-based study
Nov
Fayyad J, Sampson NA, Hwang I, Adamowski T, Aguilar-Gaxiola S, Al-Hamzawi A, et al. The descriptive epidemiology of DSM-IV adult ADHD in the world health organization world mental health surveys. Adhd-Attend Deficit. 2017;9(1):47–65.
Google Scholar
London AS, Landes SD. Cohort change in the prevalence of ADHD among US adults: evidence of a gender-specific historical period effect. J Atten Disord. 2021;25(6):771–82.
Google Scholar
Cherkasova MV, Roy A, Molina BSG, Scott G, Weiss G, Barkley RA, et al. Review: adult outcome as seen through controlled prospective follow-up studies of children with attention-deficit/hyperactivity disorder followed into adulthood. J Am Acad Child Psy. 2022;61(3):378–91.
Google Scholar
Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–65.
Google Scholar
Dalsgaard S, Ostergaard SD, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet. 2015;385(9983):2190–6.
Google Scholar
Sun SH, Kuja-Halkola R, Faraone SV, D’Onofrio BM, Dalsgaard S, Chang Z, et al. Association of psychiatric comorbidity with the risk of premature death among children and adults with attention-deficit/hyperactivity disorder. Jama Psychiat. 2019;76(11):1141–9.
Google Scholar
Hinshaw SP, Nguyen PT, O’Grady SM, Rosenthal EA. Annual research review: attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions. J Child Psychol Psyc. 2022;63(4):484–96.
Google Scholar
Young S, Adamo N, Asgeirsdottir BB, Branney P, Beckett M, Colley W, et al. Females with ADHD: an expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women. BMC Psychiatry. 2020;20(1):404.
Google Scholar
Solberg BS, Halmoy A, Engeland A, Igland J, Haavik J, Klungsoyr K. Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatr Scand. 2018;137(3):176–86.
Google Scholar
Chen Q, Hartman CA, Haavik J, Harro J, Klungsoyr K, Hegvik TA, et al. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: a population-based cross-sectional study. PLoS ONE. 2018;13(9):e0204516.
Google Scholar
Balazs J, Gyori D, Horvath LO, Meszaros G, Szentivanyi D. Attention-deficit hyperactivity disorder and nonsuicidal self-injury in a clinical sample of adolescents: the role of comorbidities and gender. BMC Psychiatry. 2018;18:34.
Google Scholar
Swanson EN, Owens EB, Hinshaw SP. Pathways to self-harmful behaviors in young women with and without ADHD: a longitudinal examination of mediating factors. J Child Psychol Psychiatry. 2014;55(5):505–15.
Google Scholar
Nock MK, Joiner TE, Gordon KH, Lloyd-Richardson E, Prinstein MJ. Non-suicidal self-injury among adolescents: diagnostic correlates and relation to suicide attempts. Psychiat Res. 2006;144(1):65–72.
Google Scholar
Fuller-Thomson E, Riviere RN, Carrique L, Agbeyaka S. The dark side of ADHD: factors associated with suicide attempts among those with ADHD in a national representative Canadian sample. Arch Suicide Res. 2022;26(3):1122–40.
Google Scholar
Meza JI, Owens EB, Hinshaw SP. Childhood predictors and moderators of lifetime risk of self-harm in girls with and without attention-deficit/hyperactivity disorder. Dev Psychopathol. 2021;33(4):1351–67.
Google Scholar
Cortese S, Moreira-Maia CR, St Fleur D, Morcillo-Penalver C, Rohde LA, Faraone SV. Association between ADHD and obesity: a systematic review and meta-analysis. Am J Psychiat. 2016;173(1):34–43.
Google Scholar
Du Rietz E, Brikell I, Butwicka A, Leone M, Chang Z, Cortese S, D’Onofrio BM, Hartman CA, Lichtenstein P, Faraone SV, Kuja-Halkola R, Larsson H. Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study. Lancet Psychiat. 2021;8:774–83.
Google Scholar
Garcia-Argibay M, du Rietz E, Lu Y, Martin J, Haan E, Lehto K, et al. The role of ADHD genetic risk in mid-to-late life somatic health conditions (vol 12, 166, 2022). Transl Psychiat. 2022;12(1);;152.
Google Scholar
Garcia-Argibay M, Du Rietz E, Hartman CA, Lichtenstein P, Chang Z, Fava C, et al. Cardiovascular risk factors in attention-deficit/hyperactivity disorder: a family design study of Swedish conscripts. Int J Meth Psych Res. 2022;31. https://doi.org/10.1002/mpr.1930.
Cortese S, Tessari L. Attention-deficit/hyperactivity disorder (ADHD) and obesity: update 2016. Curr Psychiat Rep. 2017;19(1):4.
Google Scholar
Li L, Yao H, Zhang L, Garcia-Argibay M, Du Rietz E, Brikell I, Solmi M, Cortese S, Ramos-Quiroga JA, Ribasés M, Chang Z, Larsson H. Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: a systematic review and meta-analysis. JCPP Adv. 2023;3:e12158.
Google Scholar
Guo F, Moellering DR, Garvey WT. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity (Silver Spring). 2014;22(1):110–8.
Google Scholar
Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K, Jaarsma T. The global burden of cardiovascular disease. J Cardiovasc Nurs. 2011;26(4):S5–14.
Google Scholar
de Wit L, Luppino F, van Straten A, Penninx B, Zitman F, Cuijpers P. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 2010;178(2):230–5.
Google Scholar
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabetic Med. 2006;23(11):1165–73.
Google Scholar
Song H, Fang F, Arnberg FK, Mataix-Cols D, Fernandez de la Cruz L, Almqvist C, et al. Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study. BMJ. 2019;365:l1255.
Google Scholar
Shen Q, Song H, Aspelund T, Yu JR, Lu DH, Jakobsdottir J, et al. Cardiovascular disease and subsequent risk of psychiatric disorders: a nationwide sibling-controlled study. Elife. 2022;11:e80143.
Google Scholar
Myers AK, Grannemann BD, Lingvay I, Trivedi MH. Brief report: Depression and history of suicide attempts in adults with new-onset Type 2 Diabetes. Psychoneuroendocrino. 2013;38(11):2810–4.
Google Scholar
Webb RT, Kontopantelis E, Doran T, Qin P, Creed F, Kapur N. Suicide risk in primary care patients with major physical diseases. Arch Gen Psychiat. 2012;69(3):256–64.
Google Scholar
Cook BG, Li DM, Heinrich KM. Obesity, physical activity, and sedentary behavior of youth with learning disabilities and ADHD. J Learn Disabil-Us. 2015;48(6):563–76.
Google Scholar
Franke B, Michelini G, Asherson P, Banaschewski T, Bilbow A, Buitelaar JK, et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharm. 2018;28(10):1059–88.
Google Scholar
Khalife N, Kantomaa M, Glover V, Tammelin T, Laitinen J, Ebeling H, et al. Childhood attention-deficit/hyperactivity disorder symptoms are risk factors for obesity and physical inactivity in adolescence. J Am Acad Child Psy. 2014;53(4):425–36.
Google Scholar
Leppert B, Riglin L, Wootton RE, Dardani C, Thapar A, Staley JR, et al. The effect of attention deficit/hyperactivity disorder on physical health outcomes: a 2-sample Mendelian randomization study. Am J Epidemiol. 2021;190(6):1047–55.
Google Scholar
Kim EJ, Kwon HJ, Ha M, Lim MH, Oh SY, Kim JH, et al. Relationship among attention-deficit hyperactivity disorder, dietary behaviours and obesity. Child Care Hlth Dev. 2014;40(5):698–705.
Google Scholar
Áfallasaga kvenna, vísindarannsókn HÁskóla Íslands 2023. Available from: https://afallasaga.is/english/.
Danielsdottir HB, Aspelund T, Thordardottir EB, Fall K, Fang F, Tomasson G, et al. Adverse childhood experiences and resilience among adult women: a population-based study. Elife. 2022;11:e71770.
Google Scholar
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9 – validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.
Google Scholar
Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder – the GAD-7. Arch Intern Med. 2006;166(10):1092–7.
Google Scholar
Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489–98.
Google Scholar
Kessler RC, Ustun TB. The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Meth Psych Res. 2004;13(2):93–121.
Google Scholar
Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S. An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psyc. 2012;53(3):304–12.
Google Scholar
Li L, Chang Z, Sun JW, Garcia-Argibay M, Du Rietz E, Dobrosavljevic M, et al. Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study. World Psychiatry. 2022;21(3):452–9.
Google Scholar
Chang Z, Ghirardi L, Quinn PD, Asherson P, D’Onofrio BM, Larsson H. Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiat. 2019;86(5):335–43.
Google Scholar
Zhang L, Yao HH, Li L, Du Rietz E, Andell P, Garcia-Argibay M, et al. Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(11):e2243597.
Google Scholar
Chang Z, D’Onofrio BM, Quinn PD, Lichtenstein P, Larsson H. Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study. Biol Psychiat. 2016;80(12):916–22.
Google Scholar
Chen MH, Wei HT, Chen LC, Su TP, Bai YM, Hsu JW, et al. Autistic spectrum disorder, attention deficit hyperactivity disorder, and psychiatric comorbidities: a nationwide study. Res Autism Spect Dis. 2015;10:1–6.
Google Scholar
Sattar N, Rawshani A, Franzen S, Rawshani A, Svensson AM, Rosengren A, et al. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks findings from the Swedish National Diabetes Registry. Circulation. 2019;139(19):2228–37.
Google Scholar
